[Fewer adverse effects! Treatment with atypical neuroleptics]

Pharm Unserer Zeit. 2002;31(6):558-65. doi: 10.1002/1615-1003(200211)31:6<558::AID-PAUZ558>3.0.CO;2-Y.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • Antipsychotic Agents / adverse effects*
  • Antipsychotic Agents / therapeutic use
  • Combined Modality Therapy
  • Humans
  • Schizophrenia / complications*
  • Schizophrenia / drug therapy
  • Schizophrenia / therapy
  • Schizophrenic Psychology

Substances

  • Antipsychotic Agents